Johanna Mercier

Companies

• Neurocrine BiosciencesBoard member Apr 16, 2021 to now¹
• Gilead SciencesChief Commercial Officer Jul 10, 2019 to now²
• Arcus BiosciencesBoard member Feb 7, 2024 to Feb 7, 2024³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• GSGilead Sciences GILD116,684 shares⁴$18.2M at $156.25Sep 15, 2026
• Neurocrine Biosciences NBIX6,853 shares⁵$941.3K at $137.36May 21, 2026
• ABArcus Biosciences RCUS0 shares⁶Feb 7, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 15, 2026Sold 600 shares at $145.29 of Gilead Sciences⁴
• Sep 15, 2026Sold 800 shares at $144.46 of Gilead Sciences⁴
• Sep 15, 2026Sold 1,600 shares at $143.69 of Gilead Sciences⁴
• Sep 10, 2026Shares withheld for tax 1,347 shares at $144.81 of Gilead Sciences⁷
• Sep 10, 2026Exercised options 2,797 shares of Gilead Sciences⁷
• Aug 17, 2026Sold 11,470 shares at $138.04 of Gilead Sciences⁸
• Aug 17, 2026Sold 16,530 shares at $137.37 of Gilead Sciences⁸
• Aug 17, 2026Exercised options 1,890 shares at $72.34 of Gilead Sciences⁸
• Aug 17, 2026Exercised options 23,110 shares at $66.64 of Gilead Sciences⁸
• Jul 15, 2026Sold 3,000 shares at $129.92 of Gilead Sciences⁹
• Jun 15, 2026Sold 450 shares at $125.40 of Gilead Sciences¹⁰
• Jun 15, 2026Sold 1,070 shares at $124.00 of Gilead Sciences¹⁰
• Jun 15, 2026Sold 1,480 shares at $123.42 of Gilead Sciences¹⁰
• Jun 10, 2026Shares withheld for tax 1,341 shares at $121.48 of Gilead Sciences¹¹
• Jun 10, 2026Exercised options 2,796 shares of Gilead Sciences¹¹
• May 21, 2026Exercised options 3,318 shares of Neurocrine Biosciences⁵
• May 15, 2026Sold 700 shares at $132.75 of Gilead Sciences¹²
• May 15, 2026Sold 8,374 shares at $132.23 of Gilead Sciences¹²
• May 15, 2026Sold 11,177 shares at $131.19 of Gilead Sciences¹²
• May 15, 2026Sold 7,749 shares at $130.29 of Gilead Sciences¹²
• May 15, 2026Exercised options 25,000 shares at $66.64 of Gilead Sciences¹²
• Apr 15, 2026Sold 3,000 shares at $140.96 of Gilead Sciences¹³
• Mar 16, 2026Sold 3,000 shares at $144.23 of Gilead Sciences¹⁴
• Mar 10, 2026Shares withheld for tax 3,216 shares at $148.56 of Gilead Sciences¹⁵
• Mar 10, 2026Exercised options 6,617 shares of Gilead Sciences¹⁵